End-of-day quote
Taiwan S.E.
23:00:00 23/05/2024 BST
|
5-day change
|
1st Jan Change
|
13.8
TWD
|
+1.10%
|
|
-2.47%
|
-11.82%
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
11,032
|
9,931
|
7,126
|
8,261
|
7,285
|
Enterprise Value (EV)
1 |
11,032
|
9,931
|
7,126
|
8,261
|
7,285
|
P/E ratio
|
12.5
x
|
34.9
x
|
-19
x
|
-17.8
x
|
53.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.9
x
|
1.22
x
|
-
|
0.87
x
|
0.68
x
|
EV / Revenue
|
0.9
x
|
1.22
x
|
-
|
0.87
x
|
0.68
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
16,466,017
x
|
-38,158,763
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
1.57
x
|
-
|
-
|
1.19
x
|
-
|
Nbr of stocks (in thousands)
|
527,870
|
526,830
|
527,870
|
527,870
|
527,870
|
Reference price
2 |
20.90
|
18.85
|
13.50
|
15.65
|
13.80
|
Announcement Date
|
10/03/20
|
23/03/21
|
08/03/23
|
14/03/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
12,219
|
8,113
|
-
|
9,541
|
10,693
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,071
|
90.33
|
-
|
-610.5
|
158
|
Operating Margin
|
8.76%
|
1.11%
|
-
|
-6.4%
|
1.48%
|
Earnings before Tax (EBT)
1 |
1,035
|
369.3
|
-
|
-583.1
|
185
|
Net income
1 |
882.1
|
287.5
|
-373.9
|
-462.2
|
138
|
Net margin
|
7.22%
|
3.54%
|
-
|
-4.84%
|
1.29%
|
EPS
2 |
1.670
|
0.5400
|
-0.7100
|
-0.8800
|
0.2600
|
Free Cash Flow
|
670
|
-260.2
|
-
|
-
|
-
|
FCF margin
|
5.48%
|
-3.21%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
75.96%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/03/20
|
23/03/21
|
08/03/23
|
14/03/24
|
-
|
Fiscal Period: December |
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
-
|
2,310
|
2,596
|
EBITDA
|
-
|
-
|
-
|
EBIT
1 |
-
|
28.13
|
-219.4
|
Operating Margin
|
-
|
1.22%
|
-8.45%
|
Earnings before Tax (EBT)
1 |
-
|
19.2
|
-212.2
|
Net income
1 |
-299.5
|
3.026
|
-163.9
|
Net margin
|
-
|
0.13%
|
-6.31%
|
EPS
2 |
-0.5700
|
0.0100
|
-0.3100
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
09/08/23
|
08/11/23
|
14/03/24
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
670
|
-260
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.2%
|
4.03%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
8.9%
|
3.14%
|
-
|
-
|
-
|
Assets
1 |
9,907
|
9,158
|
-
|
-
|
-
|
Book Value Per Share
|
13.30
|
-
|
-
|
13.10
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
|
278
|
281
|
-
|
-
|
-
|
Capex / Sales
|
2.27%
|
3.46%
|
-
|
-
|
-
|
Announcement Date
|
10/03/20
|
23/03/21
|
08/03/23
|
14/03/24
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -11.82% | 226M | | +3.47% | 103B | | -8.02% | 61.43B | | +72.86% | 49.09B | | +15.48% | 38.46B | | +3.64% | 32.09B | | +13.29% | 20.39B | | +12.53% | 16.78B | | +15.34% | 14.76B | | +0.39% | 13.73B |
Other Commodity Chemicals
|